Institute News
Most Popular
What To Expect in a MacTel Imaging Exam
April 29, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. This post will explain some (but not all) of the imaging exams that your eye doctor may perform during a screeni...
MacTel Project 2023 Annual Meeting Summary
February 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. The MacTel Project is an international research effort whose goal is to find the causes of, and treatments for, macular telan...
MacTel SAFE Study
March 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. LMRI is conducting the SAFE study (Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum...
2018 MacTel Project Annual Summary
The Lowy Medical Research Institute would like to announce the latest MacTel Project Newsletter, which contains important updates on the Natural History Observation and Registry (NHOR) Study, Clinical Trials, and MacTel Projects.
Results of NT-501 Phase 2 Study Published
January 16, 2019, Cumberland, RI and La Jolla, CA. The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been published in the journal o...
Neurotech Receives Priority Review of Biologics License Application for NT-501 as a Treatment for Macular Telangiectasia Type 2
June 20, 2024 LMRI would like to share the news that Neurotech has received Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a treatment for MacTel. For more information, please refer to the Neurotech...